University of Gothenburg


Skoog Group


Skoog is the leading authority on vascular dementia epidemiology, the role of vascular factors in AD and vascular cognitive impairment. The group focuses on the epidemiology of  AD, with clinical diagnostic and etiologic approaches, and a strong Molecular Epidemiology focus related to use genetic and other biomarkers.

 


Contact
Prof. Ingmar Skoog
University of Gothenburg
Institute for Neuroscience and Physiology
Section for Psychiatry and Neuroscience
Wallinsgatan 6, Hus B, Plan 3
431 41 Mölndal (Sweden)
Tel: +46-31-343-8640
Mobile: +46-709-433-681 
Fax: +46-31-776-0403
E-Mail: ingmar.skoog(at)neuro.gu.se
URL: http://www.epinep.gu.se/ 



Gustafson Group


Gustafson, author of first reports on relationships between adiposity and AD, cerebrovascular disease, and brain atrophy. Epidemiologic studies in Gothenburg are unique due to the length of time populations have been followed, clinical dementia and cognitive assessments, somatic disorder ascertainment, and routine and detailed risk and protective factor measures. All participants engage in a one day clinical examination, and world-renowned Swedish registry data is used to track those lost to follow-up. The Blennow group adds a strong focus on the measurement and development of blood and cerebrospinal fluid biomarkers for AD and genetic analyses of APOE which are used in the epidemiologic studies. Epidemiologic studies will directly benefit from Prof. Blennow’s determination of CSF and basic science biomarkers.

 


Contact
Prof. Deborah Gustafson
University of Gothenburg
Institute for Neuroscience and Physiology
Section for Neuroscience and Psychiatry
Wallinsgatan 6,  Hus B, Plan 3 
431 41 Mölndal (Sweden)
Tel: +46-31-343-8646
Mobile: +46-768-8088-65
Fax: +46-31-776-0403
E-Mail: Deb.gustafson(at)neuro.gu.se
URL: http://www.epinep.gu.se/ 

 

SUNY-Downstate Medical Center
Departments of Neurology and Medicine
450 Clarkson Avenue, Box 1213
Brooklyn, New York 11203
USA
Tel: +1 718 270 1581
Mobile: +1 347 585 2133
Fax: +1 718 270 3840
E-Mail: deborah.gustafson(at)downstate.edu



Blennow Group

Blennow is head of the Clinical Neurochemistry Laboratory at Sahlgrenska University Hospital, Göteborg, Sweden. The laboratory has a long-standing experience in CSF analyses for brain disorders. The research group has a focus on CSF biomarkers for AD with a large experience in protein analyses, immunoassays and proteomics/mass spectrometry.
Blennow is beyond doubt the most productive specialist on AD CSF biomarkers and the leading authority. Very recently his breakthrough discovery of very early diagnosis of prodromal/MCI AD caused a shift in the way early AD diagnosis is seen. 

 


Contact
Prof. Kaj Blennow
University of Gothenburg
Institute for Neuroscience and Physiology
Section for Neuroscience and Psychiatry
SU/Mölndal, V-huset 
431 80 Mölndal (Sweden)
Tel: +46-31-343-1791
Mobile: +46-704-9727-30
Fax: +46-31-343-2426
E-Mail: Kaj.Blennow(at)neuro.gu.se
URL: http://www.gu.se/